Your Location:
Home >
Browse articles >
Randomized Controlled Trial and Correlation Analysis of Gandouling Tablet in Treatment of Abnormal Lipid Metabolism of Wilson's Disease with Turbid Phlegm and Blood Stasis
Updated:2024-06-18
    • Randomized Controlled Trial and Correlation Analysis of Gandouling Tablet in Treatment of Abnormal Lipid Metabolism of Wilson's Disease with Turbid Phlegm and Blood Stasis

    • “The latest research has found that Gan Dou Ling can effectively improve the copper and lipid metabolism levels in patients with Wilson's disease, and has high clinical safety and application value. Meanwhile, the liver steatosis prediction model can accurately reflect the degree of abnormal lipid metabolism in patients.”
    • LIANG Feng , DONG Ting , TIAN Liwei , ZHAO Chenling , GUO Ruixue , WANG Qiong , ZHANG Yuqi
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 12, Pages: 121-128(2024)
    • DOI: 10.13422/j.cnki.syfjx.20241592     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 2 ) Tabs( 4 )

  • References

  • Publication Info

  • Metrics

319

Views

285

Downloads

4

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Treatment of Wilson's Disease with Intermin-gled Phlegm and Blood Stasis Syndrome by Gandouling Tablet
Effect of Gandouling Tablet Combined with Sodium Dimercaptopropane Sulfonate on Propylene Glycol and Superoxide Dismutase Levels in Serum of Patients with Phlegm and Blood Stasis Type Wilson's Disease
Construction and Validation of Integrated Traditional Chinese and Western Medicine Risk Prediction Model for Carotid Artery Plaques in 3 009 Individuals with High-risk of Stroke
Analysis of Risk Factors and Establishment of Prediction Model for Turbidity Toxicity Accumulation Syndrome in Patients with Chronic Atrophic Gastritis
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway

Related Author

XU Lei
CAI Yong-liang
JIANG Huai-zhou
WANG Yan-xin
HAN Hui
HOU Zhi-feng
MA Shou-liang
XU Ming-an

Related Institution

Dongfang Hospital of Beijing University of Chinese Medicine
The Second Clinical Medical College of Beijing University of Chinese Medicine
Hebei Key Laboratory of Turbidity Toxin Syndrome
Hebei Provincial Hospital of Traditional Chinese Medicine
Hebei University of Chinese Medicine